|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Yetter RA, Lehrer S, Ramphal R, Small PA Jr. 1980. Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity. Infect Immun 29:654–662. Yewdell JW, Bennink JR, Smith GL, Moss B. 1985. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T-lymphocytes. Proc Natl Acad Sci USA 82:1785–1789. Zambon M. 1998. Laboratory diagnosis of influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. London, England: Blackwell Science. Pp. 3–18. Zhao MQ, Arnir MK, Rice WR, Enelow RI. 2001. Type II pneumocyte-CD8+ T-cell interactions—relationship between target cell cytotoxicity and activation. Am Respir Cell Mol Biol 25:362–369. Zurcher T, Pavlovic J, Staeheli P. 1992. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 187:796–800.
|
|
|||||||||||||||
